Pulse Biosciences, Inc. (PLSE) Free cash flow 2016–2025
Pulse Biosciences, Inc. (PLSE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.4MFY2025 · since FY2016: -$8.1M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -49.3% |
| FY2024 | -$36.5M | -10.0% |
| FY2023 | -$33.2M | +30.1% |
| FY2022 | -$47.4M | +13.1% |
| FY2021 | -$54.5M | -52.3% |
| FY2020 | -$35.8M | -2.9% |
| FY2019 | -$34.8M | -43.9% |
| FY2018 | -$24.2M | -77.2% |
| FY2017 | -$13.6M | -68.1% |
| FY2016 | -$8.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice